Andrew J. Gentles

Stanford University

$5,142,395

Attributed

$5,142,395

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY2019–25

$2M$1.5M$1M$500K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,142,395 · 4

By mechanism

U01$2,526,750 · 1

R01$1,807,708 · 1

U54$433,510 · 1

R21$374,427 · 1

Top collaborators

No co-investigators on record.

Most similar at Stanford University

Same institution · by research overlap

Corey J Keller$4,827,571
Derrick Wan$2,602,600
Michael T Longaker$26,931,387
Anandi Krishnan$1,190,205
Mirabela Rusu$2,887,122

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsTumorResponseImmuneEnvironmentCellsCell TypeImmunotherapyGenetic TranscriptionCancer PatientProgramsArchitectureComputer FrameworkLearningCancer TypeInnovationMalignant Neoplasm Of OvaryImageGene ExpressionCellular ImagingBiopsyCarcinomaPhenotypeSignal Transduction